Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.

Hormone replacement therapy and cardiovascular health in the United States.

Shetty KD, Vogt WB, Bhattacharya J.

Med Care. 2009 May;47(5):600-6. doi: 10.1097/MLR.0b013e31818bfe9b.

PMID:
19319001
2.

Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women.

Angeja BG, Shlipak MG, Go AS, Johnston SC, Frederick PD, Canto JG, Barron HV, Grady D; National Registry of Myocardial Infarction 3 Investigators.

J Am Coll Cardiol. 2001 Nov 1;38(5):1297-301.

3.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
4.

Postmenopausal hormone use in women with acute coronary syndromes.

Parsons E, Newby LK, Bhapkar MV, Alexander KP, White HD, Shah SH, Bushnell CD, Califf RM; Symphony and 2nd Symphony Investigators.

J Womens Health (Larchmt). 2004 Oct;13(8):863-71.

PMID:
15671702
5.

The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.

Hillman JJ, Zuckerman IH, Lee E.

J Womens Health (Larchmt). 2004 Nov;13(9):986-92.

PMID:
15665655
6.

Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).

Robinson JG, Wallace R, Limacher M, Ren H, Cochrane B, Wassertheil-Smoller S, Ockene JK, Blanchette PL, Ko MG.

Am J Cardiol. 2008 Sep 15;102(6):693-9. doi: 10.1016/j.amjcard.2007.12.044. Epub 2008 Jul 2.

PMID:
18773990
7.

[Primary and secondary prevention of cardiovascular events through hormone replacement therapy (HRT)].

Pilz H.

Wien Med Wochenschr. 2005 Sep;155(17-18):397-403. German.

PMID:
16392437
8.

Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.

Corrao G, Zambon A, Nicotra F, Fornari C, La Vecchia C, Mezzanzanica M, Nappi RE, Merlino L, Cesana G.

Maturitas. 2007 Jul 20;57(3):315-24. Epub 2007 May 7.

PMID:
17485182
9.

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.

Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J; Women's Health Initiative Investigators.

Am J Epidemiol. 2006 Apr 1;163(7):589-99. Epub 2006 Feb 16.

PMID:
16484450
10.

The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.

Alexandersen P, Tankó LB, Bagger YZ, Qin G, Christiansen C.

Climacteric. 2006 Apr;9(2):108-18.

PMID:
16698657
11.

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J; Women's Health Initiative Investigators.

Am J Epidemiol. 2005 Sep 1;162(5):404-14. Epub 2005 Jul 20.

PMID:
16033876
13.

[Cardiovascular risk and hormone replacement therapy in menopause].

Plu-Bureau G.

Therapie. 1999 May-Jun;54(3):375-80. Review. French.

PMID:
10500454
14.

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women.

Fernández M, Calvo-Alén J, Bertoli AM, Bastian HM, Fessler BJ, McGwin G Jr, Reveille JD, Vilá LM, Alarcón GS.

J Clin Rheumatol. 2007 Oct;13(5):261-5.

PMID:
17921793
15.

Lessons learned from the WHI: HRT requires a cautious and individualized approach.

Aubuchon M, Santoro N.

Geriatrics. 2004 Nov;59(11):22-6.

PMID:
15615157
16.

The risk of stroke in postmenopausal women receiving hormonal therapy.

Lobo RA.

Climacteric. 2009;12 Suppl 1:81-5. Review.

PMID:
19811248
17.

Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.

Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S.

Pharmacoepidemiol Drug Saf. 2007 Jan;16(1):17-27.

PMID:
16794994
18.

Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.

Alexander KP, Newby LK, Hellkamp AS, Harrington RA, Peterson ED, Kopecky S, Langer A, O'Gara P, O'Connor CM, Daly RN, Califf RM, Khan S, Fuster V.

J Am Coll Cardiol. 2001 Jul;38(1):1-7.

19.

Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.

Tackett AH, Bailey AL, Foody JM, Miller JM, Apperson-Hansen C, Ohman EM, Hochman JS, Karnash SL, Califf RM, Topol EJ, Moliterno DJ.

Am Heart J. 2010 Oct;160(4):678-84. doi: 10.1016/j.ahj.2010.06.030.

PMID:
20934562
20.

Hormone replacement therapy and secondary cardiovascular prevention: a meta-analysis of randomized trials.

Cho L, Mukherjee D.

Cardiology. 2005;104(3):143-7. Epub 2005 Aug 22.

PMID:
16118493

Supplemental Content

Support Center